Journal Article Summary
The article focuses on improving the simulation of hot-melt extrusion (HME) processes, particularly by validating a method that uses model-based melt viscosity. This topic is significant because HME is a common technique in pharmaceutical manufacturing, especially for enhancing the solubility of poorly soluble drugs through the formation of amorphous solid dispersions (ASDs). However, the complexity of the HME process, which involves various parameters, makes it challenging to optimize and scale up. By simplifying the simulation process, the researchers aim to facilitate early-stage formulation development, ultimately improving drug bioavailability.
To conduct the study, the researchers used four active pharmaceutical ingredients (APIs) that had not previously been included in establishing the correlation between glass transition temperature (Tg) and melt viscosity. They characterized the ASDs formed with these APIs in terms of various physical properties, including density and specific heat capacity. The study found that using model-based melt viscosity in HME simulations generally did not compromise the accuracy of the results compared to conventional simulations. The researchers employed the commercial software Ludovic® for their simulations and compared energy consumption data from both simulation methods and actual extrusion experiments.
Despite the promising findings, the study has limitations, particularly regarding the accuracy of simulations at higher API weight fractions (30% or more). The researchers noted that the influence of specific interactions between the APIs and the polymeric matrix could lead to inaccuracies in the simulations. Patients and caregivers should discuss with healthcare professionals the implications of these findings, especially if they are involved in treatments that utilize HME-processed medications. Understanding the formulation process can help in appreciating how drug solubility and bioavailability may affect treatment outcomes.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Bochmann Esther S., Gryczke Andreas, Wagner Karl G.. Validation of Model-Based Melt Viscosity in Hot-Melt Extrusion Numerical Simulation. Pharmaceutics 2018. DOI: 10.3390/pharmaceutics10030132. PMID: 30126193. PMCID: PMC6161212.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
